Metformin Extended-Release Products – Safety update
May 28, 2020 - The FDA announced that laboratory testing has revealed levels of N-Nitrosodimethylamine (NDMA) above the agency’s acceptable intake limit in several lots of the extended-release (ER) formulation of metformin.
Download PDF
